Literature DB >> 25009811

Huge facial desmoid tumors with neck extension: a case report.

Ali Ghazipour1, Shervin Ghavami Lahiji2, Bassel Bradd3, Fariborz Saleheh1.   

Abstract

INTRODUCTION: Desmoid tumors are very rare, benign fibrous neoplasms arise from the musculoaponeurotic structures throughout the body. CASE REPORT: The patient was a seven-year old boy with a large mandibular mass growing over a period of six months. His CT-scan showed a large mass, 13 cm in diameter in the cheek area extending to the neck and trachea. Biopsy was compatible with desmoid fibromatosis. He was given neoadjovant treatment with vinblastin and methotrexate. The patient underwent a tracheostomy. Then a complete hemimandibulectomy and submandibular gland excision was performed. Finally reconstruction with latisimus dorsi free flap was performed.
CONCLUSION: Despite rarity desmoid tumors should be kept in mind of an otorhinolaryngologist as a differential diagnosis in children with head and neck mass.

Entities:  

Keywords:  Fibromatosis; Fibrous Tissue; Mandibular Diseases; Neoplasms

Year:  2014        PMID: 25009811      PMCID: PMC4087860     

Source DB:  PubMed          Journal:  Iran J Otorhinolaryngol        ISSN: 2251-7251


Introduction

Desmoid tumors are very rare, benign fibrous neoplasms arise from the musculoaponeurotic structures throughout the body. This overgrowth of fibrous tissue is typically infiltrative,well-defined, and firm (1). The overall incidence of desmoid tumors in childhood is estimated at 2–4 new diagnoses per 1 million per year and they are very uncommon in the head and neck especially in infants and young children (2,3). Only two cases of desmoid tumors of the cheek has been reported (4).Common anatomic sites for appearance of desmoid tumors include extremities, abdominal wall, and mesentery. Because this tumor is very rare (2–4 per 1 million) there are no controlled studies comparing the treatment options for this tumor but complete surgical excision of desmoid tumors is believed to be the only effective method of cure by most authors (1,5). Local recurrence rates after excision were reported to be as high as 70% (6). The pathogenesis of desmoid tumor is most likely multifactorial; genetic predisposition endocrine factors and trauma seem to play an important role (7-9). The current paper presents a case of cheek desmoid tumor with poor response to chemotherapy.

Case Report

The patient was a seven-year old boy with a large mandibular mass growing over a period of six months. A biopsy was done few months before the patient came to our center and showed a myofibroblastic lesion compatible with desmoidfibromatosis. However, due to the size of the lesion and the location surgery could cause unacceptable morbidity and cosmetic and functional outcome;We decided to give him neoadjovant treatment. Chemotherapy with vinblastin and methotrexate was initiated, but after 4 weeks of treatment the tumor continued to grow causing local pain, dyspnea, odynophagia, dysphagia and inability to close the mouth. Physical examination showed a Very big hard mass extending from the right mandible to the mouth and neck (Fig.1).
Fig 1

Clinical appearance

Clinical appearance His CT-scan showed A large mass, 13 cm in diameter in the cheek area extending to the neck and trachea; enclosing and compressing upper third of it (Fig.2).
Fig 2

CT-scan of the patient

CT-scan of the patient The patient underwent a tracheostomy in the ENT department and we decided to go for surgery. A complete hemimandibu- lectomy and submandibular gland excision was performed (Figs.3,4).
Fig 3

Photograph before surgery

Fig 4

The excised mass

Photograph before surgery The excised mass Then a reconstruction with latisimusdorsi free flap was performed (Fig.5). Surgical margins were free. Six months later reconstruction of mandible and temporo- mandibular joint was performed by using iliac crest and costo-chondral rib graft (Fig6).Good cosmetic outcome and no recurrence were seen after 1.5 years of follow up (Fig.7).
Fig 5

Outcome with latisimusdorsi free flap

Fig 6

Reconstructed mandible and temporo- mandibular joint

Fig 7

Out come after 1.5 years

Outcome with latisimusdorsi free flap Reconstructed mandible and temporo- mandibular joint Out come after 1.5 years

Discussion

Desmoid tumors are rare and account for 0.03% of all neoplasms (1) and only few cases of mandibular desmoids have been reported which suggest its exceptional location. These tumors are locally aggressive and nonmetastasizing. The cause of desmoids is not clear, but there is an association with genetics, local trauma and hormonally active states (7-9). Fewer than 15% of desmoids occur in the head and neck. There are no specific clinical or radiographic findings. Histologic findings include spindle cells with rare mitoses and an abundant collagenous stroma with infiltration of the surrounding tissues. Treatment of desmoids has been primarily surgical, but case reports of remission with chemotherapy or hormone therapy have been reported (10). Head and neck desmoids frequently involve vital structures, and residual disease is frequent after resection. Faulkner et al, (9) identified surgical margin status as the only significant prognostic factor for disease recurrence in patients with pediatric desmoid tumor. Postoperative radiation therapy leads to excellent control for positive margins and is an important adjunct if the morbidity of recurrence would be high or the chances for salvage low (5).Therefore if a desmoids tumor is resectable with acceptable morbidity and cosmetic and functional outcome, surgery is the treatment of choice. If the operative risk or cosmetic or functional morbidity is too great, radiation therapy alone to total dose of 55 to 60 Gy is recommended (3). Radiation therapy alone for gross disease leads to tumor control in 70% to 80% or more of the cases (10). The a cellular matrix may persist as a mass even if the cells are killed. Reduction in tumor size after radiation therapy may not occur. The use of chemotherapeutic and other systemic agents may be a reasonable alternative to avoid radiotherapy in the growing child, although chemotherapy also carries a risk for potentially adverse side effects, such as second malignancies, fertility problems, and cardio toxicity (11). If the margins are positive after surgery there is an advantage for patients who received adjuvant chemotherapy compared with patients who did not receive adjuvant treatment (6).

Conclusion

Primary surgery with negative margins is the treatment of choice for children with desmoids tumors. An MDT decision making and a team work is the cornerstone of success. In patients with unresectable tumors, the use of chemotherapy and/or radiotherapy in children with desmoids tumor may be a reasonable alternative.
  10 in total

1.  Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology.

Authors:  I De Wever; P Dal Cin; C D Fletcher; N Mandahl; F Mertens; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H Van Den Berghe; R Vanni; H Willén
Journal:  Mod Pathol       Date:  2000-10       Impact factor: 7.842

2.  Hypopharyngeal desmoid tumor.

Authors:  T Anderson; G S Weinstein; J Harwich; D I Rosenthal
Journal:  Otolaryngol Head Neck Surg       Date:  2000-09       Impact factor: 3.497

Review 3.  Extra-abdominal fibromatosis of the cheek: report of a case.

Authors:  Satoko Koeda; Hiroshi Nagasaka; Hiroyuki Kumamoto; Hiroshi Kawamura
Journal:  J Oral Maxillofac Surg       Date:  2005-08       Impact factor: 1.895

Review 4.  Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature.

Authors:  Saskia Buitendijk; Cees P van de Ven; Ton G Dumans; Jan C den Hollander; Peter J Nowak; Wim J Tissing; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Cancer       Date:  2005-09-01       Impact factor: 6.860

5.  Noncytotoxic drug therapy in children with unresectable desmoid tumors.

Authors:  H Lackner; C Urban; R Kerbl; W Schwinger; A Beham
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

Review 6.  Desmoid tumours.

Authors:  C J Shields; D C Winter; W O Kirwan; H P Redmond
Journal:  Eur J Surg Oncol       Date:  2001-12       Impact factor: 4.424

7.  The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors.

Authors:  B W Goy; S P Lee; F Eilber; F Dorey; J Eckardt; Y S Fu; G J Juillard; M T Selch
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

8.  Pediatric desmoid tumor: retrospective analysis of 63 cases.

Authors:  L B Faulkner; S I Hajdu; U Kher; M La Quaglia; P R Exelby; G Heller; N Wollner
Journal:  J Clin Oncol       Date:  1995-11       Impact factor: 44.544

9.  The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor.

Authors:  J J Reitamo; T M Scheinin; P Häyry
Journal:  Am J Surg       Date:  1986-02       Impact factor: 2.565

10.  The management of desmoid tumors.

Authors:  J C Acker; E H Bossen; E C Halperin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-08-01       Impact factor: 7.038

  10 in total
  1 in total

1.  Aggressive Fibromatosis, Clinicopathologic Findings of 25 Cases; A Single-Center Experience and Review of the Literature.

Authors:  Bita Geramizadeh; Fateme Jalali
Journal:  Iran J Pathol       Date:  2017-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.